Age, period and cohort trends in drug abuse hospitalizations within the total Swedish population (1975-2010)

Drug and Alcohol Dependence

Volumn 134, Issue 1, 2014, Pages 355-361

  Giordano, Giuseppe N ^a   Ohlsson, Henrik ^a   Kendler, Kenneth S ^b   Winkleby, Marilyn A ^c   Sundquist, Kristina ^a,c   Sundquist, Jan ^a,c  

^a LUND UNIVERSITY   (Sweden)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Age period cohort effects; Drug abuse; Longitudinal; Sweden; Trends

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DATA BASE; DRUG ABUSE; ETHNICITY; FEMALE; HEALTH CARE UTILIZATION; HOSPITAL DISCHARGE; HOSPITAL MANAGEMENT; HOSPITALIZATION; HUMAN; MALE; PRIORITY JOURNAL; PROBABILITY; SEX DIFFERENCE; SWEDEN; SWEDISH; TREND STUDY;

AGE-PERIOD-COHORT EFFECTS; DRUG ABUSE; LONGITUDINAL; SWEDEN; TRENDS;

ADULT; AGE FACTORS; COHORT STUDIES; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; SUBSTANCE-RELATED DISORDERS; SWEDEN; TIME FACTORS; YOUNG ADULT;

EID: 84890239151     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2013.11.011     Document Type: Article

References (51)

1. Alexandre P.K., Roebuck M.C., French M.T., Chitwood D.D., McCoy C.B. Problem drinking, health services utilization, and the cost of medical care. Rec. Dev. Alcohol. 2001, 15:285-298.
2. Arendt M., Munk-Jorgensen P., Sher L., Jensen S.O. Mortality among individuals with cannabis, cocaine, amphetamine, MDMA, and opioid use disorders: a nationwide follow-up study of Danish substance users in treatment. Drug Alcohol Depend. 2011, 114:134-139.
3. Centralförbundet för alkohol- och narkotikaupplysning Drogutvecklingen i Sverige 2011 2012, 93. Centralförbundet för alkohol- och narkotikaupplysning, Stockholm.
4. Chen K., Kandel D.B. The natural-history of drug-use from adolescence to the mid-thirties in a general-population sample. Am. J. Public Health 1995, 85:41-47.
5. Degenhardt L., Chiu W.-T., Sampson N., Kessler R.C., Anthony J.C., Angermeyer M., Bruffaerts R., de Girolamo G., Gureje O., Huang Y., Karam A., Kostyuchenko S., Lepine J.P., Mora M.E.M., Neumark Y., Ormel J.H., Pinto-Meza A., Posada-Villa J., Stein D.J., Takeshima T., Wells J.E. Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys. PLoS Med. 2008, 5:1053-1067.
6. DiCola L.A., Gaydos L.M., Druss B.G., Cummings J.R. Health insurance and treatment of adolescents with co-occurring major depression and substance use disorders. J. Am. Acad. Child Adolesc. Psychiatry 2013, 52:953-960.
7. European Monitoring Centre for Drugs and Drug Addiction Annual Report on the State of the Drugs Problem in Europe, Lisbon 2011.
8. European Monitoring Centre for Drugs and Drug Addiction Annual Report on the State of the Drugs Problem in Europe, Lisbon 2013, accessed on 17th October. http://www.emcdda.europa.eu/publications/searchresults%3Faction=list%26type=PUBLICATIONS%26SERIES_PUB=w36.
9. Fielding A., Goldstein H. Cross-Classified and Multiple Membership Structures in Multilevel Models: An Introduction and Review 2006, DfES Publications, Nottingham, UK.
10. Folkhälsoinstitut S. Narkotikabruket i Sverige 2010, 16. Östersund, Sweden.
11. Fothergill K.E., Ensminger M.E. Childhood and adolescent antecedents of drug and alcohol problems: a longitudinal study. Drug Alcohol Depend. 2006, 82:61-76.
12. French M.T., McGeary K.A., Chitwood D.D., McCoy C.B. Chronic illicit drug use, health services utilization and the cost of medical care. Soc. Sci. Med. 2000, 50:1703-1713.
13. French M.T., Roebuck M.C., McGeary K.A., Chitwood D.D., McCoy C.B. Using the drug abuse screening test (DAST-10) to analyze health services utilization and cost for substance users in a community-based setting. Subst. Use Misuse 2001, 36:927-946.
14. Garoupa N. Optimal law enforcement and the economics of the drug market: some comments on the Schengen Agreements. Int. Rev. Law Econ. 1997, 17:521-535.
15. Hicks B.M., Blonigen D.M., Kramer M.D., Krueger R.F., Patrick C.J., Iacono W.G., McGue M. Gender differences and developmental change in externalizing disorders from late adolescence to early adulthood: a longitudinal twin study. J. Abnorm. Psychol. 2007, 116:433-447.
16. Holdcraft L.C., Iacono W.G. Cross-generational effects on gender differences in psychoactive drug abuse and dependence. Drug Alcohol Depend. 2004, 74:147-158.
17. Hser Y.I., Hoffman V., Grella C.E., Anglin M.D. A 33-year follow-up of narcotics addicts. Arch. Gen. Psychiatry 2001, 58:503-508.
18. Johnson T., Fendrich M. Modeling sources of self-report bias in a survey of drug use epidemiology. Ann. Epidemiol. 2005, 15:381-389.
19. Johnston L.D., O'Malley P.M., Bachman J.G., Schulenberg J.E. Monitoring the Future National Survey Results on Drug Use, 1975-2010: Volume I, Secondary School Students 2011, Institute for Social Research, Ann Arbor, MI.
20. Kendler K.S., Maes H.H., Sundquist K., Ohlsson H., Sundquist J. Genetic and family and community environmental effects on drug abuse in adolescence: a Swedish National Twin and Sibling Study. Am. J. Psychiatry 2013, 30:12101300.
21. Kendler K.S., Ohlsson H., Sundquist K., Sundquist J. Within-family environmental transmission of drug abuse: a Swedish National Study. JAMA Psychiatry 2013, 70:235-242.
22. Kendler K.S., Prescott C.A., Myers J., Neale M.C. The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch. Gen. Psychiatry 2003, 60:929-937.
23. Kendler K.S., Sundquist K., Ohlsson H., Palmer K., Maes H., Winkleby M.A., Sundquist J. Genetic and familial-environmental influences on risk for drug abuse: a National Swedish Adoption Study. Arch. Gen. Psychiatry 2012, 69:690-697.
24. Kerr W.C., Greenfield T.K., Bond J., Ye Y., Rehm J. Age-period-cohort influences on trends in past year marijuana use in the US from the 1984, 1990, 1995 and 2000 National Alcohol Surveys. Drug Alcohol Depend. 2007, 86:132-138.
25. Kloos A., Weller R.A., Chan R., Weller E.B. Gender differences in adolescent substance abuse. Curr. Psychiatry Rep. 2009, 11:120-126.
26. Leao T.S., Johansson L.M., Sundquist K. Hospitalization due to alcohol and drug abuse in first- and second-generation immigrants: a follow-up study in Sweden. Subst. Use Misuse 2006, 41:283-296.
27. Mason K.O., Mason W.M., Winsborough H.H., Kenneth Poole W. Some methodological issues in cohort analysis of archival data. Am. Sociol. Rev. 1973, 38:242-258.
28. Miech R., Koester S. Trends in U.S., past-year marijuana use from 1985 to 2009: an age-period-cohort analysis. Drug Alcohol Depend. 2012, 124:259-267.
29. Nyabadza F., Hove-Musekwa S.D. From heroin epidemics to methamphetamine epidemics: modelling substance abuse in a South African province. Math. Biosci. 2010, 225:132-140.
30. Olsson B., Wahren C.A., Byqvist S. Det tunga narkotikamissbrukets omfattning i Sverige 2001, Centralförbundet för alkohol- och narkotikaupplysning, Stockholm.
31. Patterson K.M., Holman C.D., English D.R., Hulse G.K., Unwin E. First-time hospital admissions with illicit drug problems in indigenous and non-indigenous Western Australians: an application of record linkage to public health surveillance. Aust. N.Z. J. Public Health 1999, 23:460-463.
32. Perkonigg A., Pfister H., Hoefler M., Froehlich C., Zimmermann P., Lieb R., Wittchen H.-U. Substance use and substance use disorders in a community sample of adolescents and young adults: incidence, age effects and patterns of use. Eur. Addict. Res. 2006, 12:187-196.
33. Piontek D., Kraus L., Pabst A., Legleye S. An age-period-cohort analysis of cannabis use prevalence and frequency in Germany, 1990-2009. J. Epidemiol. Community Health 2012, 66:908-913.
34. Rasbash J., Charlton C., Browne W., Healy M., Cameron B. MLwiN Version 2.27. Centre for Multilevel Modelling 2012, University of Bristol.
35. Rivers J.E., Komaroff E., Kibort A.C. Access to health and human services for drug users: an urban/rural community systems perspective. Subst. Use Misuse 1999, 34:707-725.
36. Robins L.N. The natural history of drug abuse. Acta Psychiatr. Scand. 1980, 62:7-20.
37. Roxburgh A., Hall W.D., Degenhardt L., McLaren J., Black E., Copeland J., Mattick R.P. The epidemiology of cannabis use and cannabis-related harm in Australia 1993-2007. Addiction 2010, 105:1071-1079.
38. Santora P.B., Hutton H.E. Longitudinal trends in hospital admissions with co-occurring alcohol/drug diagnoses, 1994-2002. J. Subst. Abuse Treat. 2008, 35:1-12.
39. SAS Institute Inc SAS ONLINE DOC Version 9. 3 2008, SAS Institute Inc, Cary, NC.
40. Smith D.E. An upper/downer perfect storm: the coming world-wide drug epidemic. J. Psychoactive Drugs 2006, 38:535-536.
41. Smith H.L. Advances in age-period-cohort analysis. Sociol. Methods Res. 2008, 36:287-296.
42. Smothers B.A., Yahr H.T. Alcohol use disorder and illicit drug use in admissions to general hospitals in the United States. Am. J. Addict. 2005, 14:256-267.
43. Snijders T., Busker R. Multilevel Analysis: An Introduction to Basic and Advanced Multilevel Modelling 1999, Sage Publications, London.
44. SOU Vägvalet - den narkotikapolitiska utmaningen 2000, 33.
45. Sundquist K., Frank G. Urbanization and hospital admission rates for alcohol and drug abuse: a follow-up study of 4.5 million women and men in Sweden. Addiction 2004, 99:1298-1305.
46. United Nations Office on Drugs and Crime Sweden's Successful Drug Policy: A Review of the Evidence, New York 2007.
47. United Nations Office on Drugs and Crime World Drug Report, New York 2012.
48. Wetherington C.L. Sex-gender differences in drug abuse: a shift in the burden of proof?. Exp. Clin. Psychopharmacol. 2007, 15:411-417.
49. World Health Organization (WHO) Guide to Drug Abuse Epidemiology 2000, World Health Organization, Geneva.
50. Yang Y., Land K.C. Age-period-cohort analysis of repeated cross-section surveys-fixed or random effects?. Sociol. Methods Res. 2008, 36:297-326.
51. Yu H.-Y.E. The prescription drug abuse epidemic. Clin. Lab. Med. 2012, 32:361-377.